Genprex GNPX Q1 2026 Earnings Continued RD Investment as Gene Therapy Pipeline Progresses NKE Q1 2026 Earnings Strong EPS Beat Amidst Uncertain Revenue Landscape GT Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment APOS Q1 2026 Earnings Modest EPS Miss Amid Stable Bond Performance Teck Resources Q1 2026 Earnings Strong EPS Beat Amid Market Headwinds JBSS Q1 2026 Earnings EPS Surprises to the Upside Beating Estimates by Over 21